Search

Robert W. Downs

Examiner (ID: 17152)

Most Active Art Unit
2308
Art Unit(s)
2762, 4762, 2309, 2308, 2165
Total Applications
581
Issued Applications
448
Pending Applications
24
Abandoned Applications
109

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15663821 [patent_doc_number] => 10596116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-24 [patent_title] => Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders [patent_app_type] => utility [patent_app_number] => 15/613847 [patent_app_country] => US [patent_app_date] => 2017-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 59 [patent_no_of_words] => 23709 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613847 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/613847
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders Jun 4, 2017 Issued
Array ( [id] => 12091348 [patent_doc_number] => 20170348442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 15/611577 [patent_app_country] => US [patent_app_date] => 2017-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 41439 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611577 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/611577
COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS May 31, 2017 Abandoned
Array ( [id] => 14464805 [patent_doc_number] => 20190184042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES [patent_app_type] => utility [patent_app_number] => 16/305284 [patent_app_country] => US [patent_app_date] => 2017-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42715 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305284 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/305284
PET imaging with PD-L1 binding polypeptides May 30, 2017 Issued
Array ( [id] => 12637596 [patent_doc_number] => 20180104362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => PRE-AND-INTRA-OPERATIVE LOCALIZATION OF PENILE SENTINEL NODES [patent_app_type] => utility [patent_app_number] => 15/610102 [patent_app_country] => US [patent_app_date] => 2017-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6262 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15610102 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/610102
Pre-and-intra-operative localization of penile sentinel nodes May 30, 2017 Issued
Array ( [id] => 12238548 [patent_doc_number] => 20180071411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID' [patent_app_type] => utility [patent_app_number] => 15/602141 [patent_app_country] => US [patent_app_date] => 2017-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8102 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602141 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/602141
STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID May 22, 2017 Abandoned
Array ( [id] => 12052542 [patent_doc_number] => 20170328886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'SYSTEMS AND METHODS FOR DETERMINING THERAPEUTIC UPTAKE AND DOSING' [patent_app_type] => utility [patent_app_number] => 15/594131 [patent_app_country] => US [patent_app_date] => 2017-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11252 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594131 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/594131
SYSTEMS AND METHODS FOR DETERMINING THERAPEUTIC UPTAKE AND DOSING May 11, 2017 Abandoned
Array ( [id] => 14102365 [patent_doc_number] => 20190092858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION [patent_app_type] => utility [patent_app_number] => 16/098488 [patent_app_country] => US [patent_app_date] => 2017-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098488 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098488
CD31 May 2, 2017 Issued
Array ( [id] => 12000130 [patent_doc_number] => 20170304284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging' [patent_app_type] => utility [patent_app_number] => 15/495971 [patent_app_country] => US [patent_app_date] => 2017-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 198 [patent_figures_cnt] => 198 [patent_no_of_words] => 20204 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495971 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/495971
Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging Apr 23, 2017 Issued
Array ( [id] => 16981310 [patent_doc_number] => 20210225547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => HIGH SPECIFIC ACTIVITY PREPARATION OF F-18 TETRAFLUOROBORATE [patent_app_type] => utility [patent_app_number] => 16/095865 [patent_app_country] => US [patent_app_date] => 2017-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10536 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095865 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/095865
High specific activity preparation of F-18 tetrafluoroborate Apr 23, 2017 Issued
Array ( [id] => 13137569 [patent_doc_number] => 10086096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-02 [patent_title] => Triazine based radiopharmaceuticals and radioimaging agents [patent_app_type] => utility [patent_app_number] => 15/492933 [patent_app_country] => US [patent_app_date] => 2017-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16799 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492933 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/492933
Triazine based radiopharmaceuticals and radioimaging agents Apr 19, 2017 Issued
Array ( [id] => 19338561 [patent_doc_number] => 12048732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-30 [patent_title] => Methods of treating breast cancer [patent_app_type] => utility [patent_app_number] => 16/093508 [patent_app_country] => US [patent_app_date] => 2017-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 46 [patent_no_of_words] => 45739 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093508 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/093508
Methods of treating breast cancer Apr 13, 2017 Issued
Array ( [id] => 12023959 [patent_doc_number] => 20170314056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'METHOD OF USING NEAR INFRARED FLUORESCENT DYES FOR IMAGING AND TARGETING CANCERS' [patent_app_type] => utility [patent_app_number] => 15/487320 [patent_app_country] => US [patent_app_date] => 2017-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 30717 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487320 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/487320
METHOD OF USING NEAR INFRARED FLUORESCENT DYES FOR IMAGING AND TARGETING CANCERS Apr 12, 2017 Abandoned
Array ( [id] => 11756045 [patent_doc_number] => 20170202912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA' [patent_app_type] => utility [patent_app_number] => 15/471992 [patent_app_country] => US [patent_app_date] => 2017-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 27724 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471992 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/471992
OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA Mar 27, 2017 Abandoned
Array ( [id] => 11962131 [patent_doc_number] => 20170266285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED HEMOGLOBIN-BASED THERAPEUTIC AGENT FOR CANCER TARGETING TREATMENT AND DIAGNOSTIC IMAGING' [patent_app_type] => utility [patent_app_number] => 15/469978 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 10299 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469978 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/469978
Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging Mar 26, 2017 Issued
Array ( [id] => 17434830 [patent_doc_number] => 11260136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Radio-pharmaceutical complexes [patent_app_type] => utility [patent_app_number] => 16/087040 [patent_app_country] => US [patent_app_date] => 2017-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13079 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087040 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/087040
Radio-pharmaceutical complexes Mar 19, 2017 Issued
Array ( [id] => 11713692 [patent_doc_number] => 20170182192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE' [patent_app_type] => utility [patent_app_number] => 15/459078 [patent_app_country] => US [patent_app_date] => 2017-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2057 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459078 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/459078
METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE Mar 14, 2017 Abandoned
Array ( [id] => 14043545 [patent_doc_number] => 20190077879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => CONJUGATES ENHANCING TOTAL CELLULAR ACCUMULATION [patent_app_type] => utility [patent_app_number] => 16/085141 [patent_app_country] => US [patent_app_date] => 2017-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7066 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/085141
Conjugates enhancing total cellular accumulation Mar 14, 2017 Issued
Array ( [id] => 13955597 [patent_doc_number] => 20190054142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA [patent_app_type] => utility [patent_app_number] => 16/079787 [patent_app_country] => US [patent_app_date] => 2017-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079787 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/079787
ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA Feb 23, 2017 Abandoned
Array ( [id] => 13955699 [patent_doc_number] => 20190054193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => ACTIVITY BASED PROBE AND USES THEREOF FOR IMAGING [patent_app_type] => utility [patent_app_number] => 16/077879 [patent_app_country] => US [patent_app_date] => 2017-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077879 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/077879
Activity based probe and uses thereof for imaging Feb 15, 2017 Issued
Array ( [id] => 12000316 [patent_doc_number] => 20170304471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'ANTICANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 15/427355 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14484 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427355 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/427355
Anticancer therapy Feb 7, 2017 Issued
Menu